The Selective WEE1 Inhibitor Azenosertib Shows Synergistic Antitumor Activity with <i>KRAS</i> G12C Inhibitors in Preclinical ModelsNathan M. Jameson, Mark R. Lackner|Cancer Research Communications|2025Cited by 6
Azenosertib Is a Potent and Selective WEE1 Kinase Inhibitor with Broad Antitumor Activity Across a Range of Solid TumorsJianhui Ma, Mark R. Lackner|Molecular Cancer Therapeutics|2025Cited by 6